- American City Business Journals•32 minutes ago
Boston Scientific Corp. announced better-than-expected sales for the second quarter and said it expects full-year revenue to grow as much as 12 percent. The Boston Business Journal reports that Boston Scientific raised its full-year outlook for the second time in months, to a range of $8.27 billion to $8.37 billion . The Boston Business Journal has more on that deal .
- Benzinga•1 hour ago
Boston Scientific Corporation (NYSE: BSX ) released its financial results for the second quarter. While adjusted earnings were in line with the Street estimates, revenue exceeded both its own guidance ...
Boston Scientific CorporationNYSE
Pre-Market: 23.800.14 (0.59%) as of 8:47 AM EDT
|Bid||23.62 x 300|
|Ask||23.75 x 4000|
|52wk Range||14.18 - 24.45|
|Day's Range||23.52 - 24.11|
|Avg Vol (3m)||10,943,963|
As of 4:01 PM EDT. Market closed.